These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions. Nielsen PS; Riber-Hansen R; Steiniche T Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457 [TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit. Kim YJ; Jung CJ; Na H; Lee WJ; Chang SE; Lee MW; Park CS; Lim Y; Won CH Diagn Pathol; 2022 Apr; 17(1):41. PubMed ID: 35484605 [TBL] [Abstract][Full Text] [Related]
4. A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma. Uguen A; Talagas M; Costa S; Duigou S; Bouvier S; De Braekeleer M; Marcorelles P Diagn Pathol; 2015 Oct; 10():195. PubMed ID: 26503349 [TBL] [Abstract][Full Text] [Related]
5. Preferentially Expressed Nuclear Antigen in Melanoma Expression in Melanocytic Activation (Melanotic Macule) of the Nail Unit. A Potential Diagnostic Pitfall? A Study of 3 Cases. Perrin C Am J Dermatopathol; 2022 Jul; 44(7):499-502. PubMed ID: 35220324 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of epithelial and melanocitic markers with double sequential immunohistochemical staining in differentiating melanoma in situ from invasive melanoma. Parra-Medina R; Morales SD Ann Diagn Pathol; 2017 Feb; 26():70-74. PubMed ID: 27594302 [TBL] [Abstract][Full Text] [Related]
7. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. El Shabrawi-Caelen L; Kerl H; Cerroni L Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366 [TBL] [Abstract][Full Text] [Related]
8. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors. Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709 [TBL] [Abstract][Full Text] [Related]
9. Suprabasal spread of melanocytes in dysplastic nevi and melanoma in situ: Ki-67-labeling rate of junctional melanocytes and suprabasal cells may be a helpful clue to the diagnosis. Hall BJ; LeBoit PE Am J Surg Pathol; 2014 Aug; 38(8):1111-7. PubMed ID: 24805862 [TBL] [Abstract][Full Text] [Related]
10. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA. Sundram U; Harvell JD; Rouse RV; Natkunam Y Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225 [TBL] [Abstract][Full Text] [Related]
11. Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation. Perrin C; Michiels JF; Pisani A; Ortonne JP Am J Dermatopathol; 1997 Oct; 19(5):462-7. PubMed ID: 9335239 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16. Milman T; Zhang Q; Ang S; Elder D; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC Am J Ophthalmol; 2021 Feb; 222():148-156. PubMed ID: 33002486 [TBL] [Abstract][Full Text] [Related]
14. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells. Kopera D; Hohenleutner U; Stolz W; Landthaler M Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755 [TBL] [Abstract][Full Text] [Related]
15. PRAME expression in melanocytic lesions of the nail. Parra O; Linos K; Li Z; Yan S J Cutan Pathol; 2022 Jul; 49(7):610-617. PubMed ID: 35294053 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic application of cyclin D1 fluorescent in situ hybridization for histologically undetermined early lesions of acral melanoma in situ: A case series. Cho-Vega JH; Cao T; Ledon J; Moller M; Avisar E; Elgart G; Tan JH; Fan YS; Grichnik JM Ann Diagn Pathol; 2021 Feb; 50():151681. PubMed ID: 33341705 [TBL] [Abstract][Full Text] [Related]
17. Lichenoid dermatoses with pseudomelanocytic nests vs inflamed melanoma in situ: A comparative study. Panse G; McNiff JM J Cutan Pathol; 2021 Jun; 48(6):745-749. PubMed ID: 33350494 [TBL] [Abstract][Full Text] [Related]
18. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases. Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332 [TBL] [Abstract][Full Text] [Related]
19. Another point of view on p16 and Ki67 expression in melanocytic and non-melanocytic cutaneous lesions. Donati P; Paolino G; Panetta C; Cota C; Zaccarini M; Muscardin L Acta Dermatovenerol Croat; 2013; 21(3):149-54. PubMed ID: 24183217 [TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinomas are populated by melanocytes and Langerhans [correction of Langerhan's] cells. Florell SR; Zone JJ; Gerwels JW Am J Dermatopathol; 2001 Feb; 23(1):24-8. PubMed ID: 11176048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]